SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001561743-17-000027
Filing Date
2017-06-26
Accepted
2017-06-26 07:40:33
Documents
4
Period of Report
2017-06-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8-kjune212017xmaterialagr.htm 8-K 37387
2 SUPPLY AGREEMENT kindred-zimetacommercialma.htm EX-10.1 329487
3 PURCHASE AGREEMENT spvpurchaseagreement.htm EX-10.2 238130
4 PRESS RELEASE june262017pr.htm EX-99.1 12521
  Complete submission text file 0001561743-17-000027.txt   618621
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36225 | Film No.: 17928891
SIC: 2834 Pharmaceutical Preparations